Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 10/20 | 0.39 |
| ▸ | GSK3A | P49840 | 9/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.36 |
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.36 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.36 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5549013 | 0.85 | ALPL (0.41) | GSK3BGSK3AADORA1 | |
| SCHEMBL3528837 | 0.82 | GSK3B (0.47) | GSK3BGSK3AADORA1 | |
| SCHEMBL5548595 | 0.82 | GSK3B (0.48) | GSK3BGSK3AALDH1A1 | |
| SCHEMBL5550039 | 0.82 | GSK3A (0.46) | GSK3BGSK3AADORA1 | |
| SCHEMBL5549315 | 0.82 | DCTPP1 (0.47) | ALDH1A1 | |
| SCHEMBL5549249 | 0.81 | CA1 (0.46) | GAA | |
| SCHEMBL5545002 | 0.81 | GSK3A (0.51) | GSK3BGSK3AADORA1 | |
| SCHEMBL5543493 | 0.81 | GSK3B (0.50) | GSK3BGSK3AADORA1 | |
| SCHEMBL5545469 | 0.81 | ADORA1 (0.41) | GSK3BGSK3AADORA1ALDH1A1 | |
| SCHEMBL3523080 | 0.79 | GSK3A (0.50) | GSK3BGSK3AGAAADORA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1678180-B1 | SUBSTITUTED 2H-[1,2,4]TRIAZOLO 4,3-A PYRAZINES AS GSK-3 INHIBITORS | PFIZER PROD INC (US) | 2007-08-08 | — | — | EP | disclosed |